Track topics on Twitter Track topics that are important to you
On behalf of all of our staff members, we welcome you to our Web site. Here you will learn more about our corporate vision , values , goals ,products
and services as well as our affiliated companies.
Vacsera is the leading company in the field of biological products &vaccines
manufacturing in Egypt and the Middle East.
We are focused on pursuing strategic investment opportunities in a number
of sectors within the pharmaceutical and biopharmaceutical industries.
These include research and development, manufacturing, distribution, and intellectual property acquisitions.
51 Wizaret El-Zeraa - Agouza
Phone: (202) 76 111 11
Fax: (202) 33 698 72
* Says its subsidiary Pharmally Investment Limited will buy up to 15.6 million shares of Pharmvac Biological Holding Limited at up to $15.6 million
* Says Harbin Weike Biotechnology Development Company will use the trademark as price to acquire 10 percent stake in its subsidiary Pharmvac Biological
NewsA plant that manufactures vaccines and drugs to protect soldiers from chemical and biological attacks has opened in north Florida.
Chinese vaccine and biologic products developer and manufacturer Shenzhen Kangtai Biological Products has announced the pricing for an initial public offering (IPO) of shares to raise ¥138.2m ($20.08...
SummaryExpress Scripts Holding Company Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW...
Dec 5 (Reuters) - Beijing Tiantan Biological Products Corp Ltd
Boehringer Ingelheim will sell five of its animal health products in the U.S. to settle a complaint by the Federal Trade Commission (FTC) that its planned swap of businesses with Sanofi would be antic...
NewsAllergan to acquire GI disease subsidiary of Rhythm Holding Company, LLC, expanding innovative gastroenterology pipeline.
DNA vaccines have great potential as preventive or therapeutic vaccines against viral, bacterial, or parasitic diseases as well as cancer, and may also be used as gene therapy products. Although many ...
The widely recommended standard schedule of hepatitis B vaccine for adults is months 0, 1 and 6, which takes 6 months to complete. Rapid completion of one vaccination schedule is important to adults ...
Lyophilization of vaccines is advantageous for the distribution and storage of thermally labile products, particularly in regions where cold chain management is difficult. To date, current lyophilized...
The pervasive smokeless tobacco (SLT) consumption and diseases related to its use is a hot topic for the public discussion. In this study, concentrations of chromium (Cr) were measured in different SL...
A variety of different mRNA-based drugs are currently in development. This became possible, since major breakthroughs in RNA research during the last decades allowed impressive improvements of transla...
The goal of this clinical protocol is to perform a randomized crossover study to determine the energy cost of holding the MedGem® device above a person's normal resting metabolic rate (RM...
Kangaroo holding is a skin-to-skin method of holding a baby. Many research studies have investigated the maternal and infant benefits associated with kangaroo holding. The purpose of thi...
The aim of this study is through a randomized clinical trial, double blind, splith-mouth, evaluate the various types of protocols and clinical efficacy in the reduction or even elimination...
The primary objective is to determine if kangaroo holding in the first week after birth influences the stress levels of mothers who have delivered their infants prematurely and who require...
Ten infants undergoing therapeutic hypothermia for hypoxic-ischemic encephalopathy will be enrolled in a new protocol that will allow mothers to hold their infants during the hypothermia t...
On behalf of all of our staff members, we welcome you to our Web site. Here you will learn more about our corporate vision , values , goals ,productsand services as well as our affiliated companies.Va...
ASCIInc is a premiere Healthcare and Life Science Company that understands the labyrinth of possibilities involving immunization and vaccination programs utilizes an intelligent eidetic system includi...
Humanity has come a long way. With gradual effort, today we are in a position to prevent major life-threatening illnesses. However the quest for healthy life is an ever-lasting journey. Biological E. ...
Embrex, Inc. develops and markets biological delivery technology and biological products to increase the productivity andprofitability of the global poultry industry. Embrex has developed and commerci...
AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. The company is developing a...
We have published hundreds of Vacsera Biological Products & Vaccines Holding Company news stories on BioPortfolio along with dozens of Vacsera Biological Products & Vaccines Holding Company Clinical Trials and PubMed Articles about Vacsera Biological Products & Vaccines Holding Company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vacsera Biological Products & Vaccines Holding Company Companies in our database. You can also find out about relevant Vacsera Biological Products & Vaccines Holding Company Drugs and Medications on this site too.
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...